01 October 2015: Clinical Research
Assessment of Pain Intensity in Patients with Dentin Hypersensitivity After Application of Prophylaxis Paste Based on Calcium Sodium Phosphosilicate Formula
Renata Chałas ABDEFG , Ilona Wójcik-Chęcińska ABCEF , Jolanta Zamościńska BDE , Teresa Bachanek EFG
DOI: 10.12659/MSM.894189
Med Sci Monit 2015; 21:2950-2955
Abstract
BACKGROUND: One of many functions of the pulp-dentin complex is sensory function. Acute, situated, receding pain after the cessation of the stimulus action is called dentin pain. Dentin hypersensitivity has been described as one of the most painful and least successfully treated chronic ailments of teeth. The aim of this research was the clinical evaluation of the effectiveness of professional polishing paste containing calcium sodium phosphosilicate formula (NovaMin) in eliminating dentin hypersensitivity after a single application.
MATERIAL AND METHODS: The study comprised 92 teeth with dentin hypersensitivity diagnosed on the basis of history and clinical examination. The pain reaction of exposed dentine was induced by tactile and dehydrating stimuli, asking patients to assess the severity of pain on the VAS scale. Clinical trial and survey were carried out twice: before and 1 week after the application of the polishing paste.
RESULTS: After the application of the examined paste, the percentage of teeth reacting with a severe pain to the touch of the probe decreased from 16.3% to 4.3%, and with a moderate pain from 42.4% to 12%. Examination after applying dehydrating stimulus a week after carrying out the application showed a decrease in the proportion of teeth with strong pain from 28.3% to 0% and moderate pain from 38% to 15.2%. The lack of pain increased from 12% to about 50%.
CONCLUSIONS: The use of prophylactic professional paste with NovaMin formula in in-office procedure provides the reduction of dentin hypersensitivity noticeable by 1 week after application.
Keywords: Dental Pulp - drug effects, Dentin Sensitivity - prevention & control, Fluorides - chemistry, Glass - chemistry, Nitrates - chemistry, Pain - diagnosis, pain management, Pain Measurement - methods, Phosphates - chemistry, Tooth - drug effects, Toothbrushing, Toothpastes, visual analog scale, young adult
Background
Sensory function is one of many functions of the pulp-dentin complex. Regardless of the type of stimulus, the only reaction of the pulp is pain [1]. Dentistry recognizes concepts of “pulp pain “ and “dentin pain” [1]. A dull and difficult to locate pain lasting longer than the acting stimulus is pulp pain, caused by C-fibers activation and frequently confirming pulpitis. Acute, situated, receding pain after the cessation of the stimulus is dentin pain, caused by activation of nerve fibers A-δ [1] and is found in many different ailments, including dentin hypersensitivity [2–4].
In 1979, Merskey distinguished and characterized pain in several categories for the International Association for the Study of Pain (IASP) [5]. According to the current definition, pain is an unpleasant sensory or emotional experience, associated with actual or potential tissue damage or described in terms of such damage [5].
Because organs and tissues located in the oral cavity are well supplied with blood and nerve endings, all pathological processes in the region cause high-intensity pain [6]. The perception of pain originating in the mouth is perceived as disproportionately severe in relation to the actual cause of the pain, as compared to the rest of the body [1]. Pain, despite being a negative sensation, provides the physician with much information. Knowledge of the essence of pain, as well as its types or radiation, is often the basis for setting the correct diagnosis and treatment [5].
In physiological conditions, when the pulp-dentin complex is protected by enamel and root cementum, such stimuli as cold, hot, sweet and acid foods, and tooth brushing or touching, do not induce pain in the pulp [7]. When it comes to exposing the dentine and opening of outlets of dentinal tubules with maintaining their patency toward the pulp, harmless external stimuli (thermal, dehydrative, tactile, chemical or osmotic) cause excessive pain response in the pulp [8,9]. The described clinical condition, which cannot be attributed to another disease or tooth defect, has been defined as dentin hypersensitivity [3,9–11]. It has been described as one of the most painful and least successfully treated chronic ailments of the teeth [12].
Factors contributing to exposure of dentin are attrition, abrasion, erosion and abfraction, loss of cement in the cervical region following periodontal disease, or loss of organic matter of hard tissues of the tooth after teeth whitening [3,4,8–11,13]. According to the hydrodynamic theory explaining the formation of dentin hypersensitivity in pulp pain, the stimuli acting on the exposed dentine surface cause movement of the fluid in the dentinal tubules, stimulating pulp nerve receptors. The stimulation is transmitted to the central nervous system and is experienced as pain [8,10,13]. The intensity of the pain varies from strong with high intensity to mild with moderate intensity, which may be because not all patients with hypersensitive dentin seek help from a dentist. The incidence of the disease in the adult population ranges from 8% to more than 50% [1,4,10,14].
Despite the presence on the market of many therapeutic agents to be used by patients at home and professional ones to be used in the dental office, there is no completely effective treatment that quickly and permanently eliminates dentin hypersensitivity [3,12,15–18].
A remedy for this still-current problem is a new product based on inorganic amorphous calcium and sodium phosphosilicates belonging to the group of materials known as bioactive glass, with the brand name NovaMin. The NovaMin concentration in NUPRO® Sensodyne® Prophylaxis Paste is 15% compared to 5% in a tooth paste.
The aim of the study was the clinical evaluation of the effectiveness of the professional polishing paste NUPRO® Sensodyne® Prophylaxis Paste in eliminating dentin hypersensitivity after a single application on the exposed, hypersensitive dentin.
Material and Methods
The research comprised 92 teeth with dentin hypersensitivity diagnosed based on history and clinical examination in 23 patients (14 women and 9 men) aged 21–66 years. Before starting treatment, patients responded to questions contained in a specially prepared questionnaire, including questions about the duration and severity of pain. The survey included the type of pain-inducing stimuli (cold, warm, touching, brushing, sweet, sour) and the intensity according to patient subjective assessment. In this aspect, history-taking was performed twice: in survey 0 (preliminary) and in survey 1 (1 week after the application of NUPRO® Sensodyne® Prophylaxis Paste, Dentsply). In addition, the survey included questions about hygienic habits of patients: frequency of tooth brushing, the hardness of toothbrush, and the use of assistive oral hygiene and dietary habits.
In the clinical trial, the number of lesions with exposed dentin on each tooth and their location, together with an indication of the likely causes and diagnosis, were assessed. Dentin hypersensitivity mostly occurred in abrasion (49 teeth), post-treatment hypersensitivity mostly occurred after scaling and orthodontic treatment (34 teeth), erosion occurred in 8 teeth, and in 1 tooth attrition was diagnosed. Hypersensitivity distribution by sex and diagnosis are presented in Table 1.
The pain reaction of exposed dentine, with patient consent, was induced by touching with a blunt probe (tactile stimulus) and by the air flow emitted from the blower for 1 s at a distance of 1cm (dehydrating stimulus), asking patients to assess pain intensity on the VAS scale. In each test before and 1 week after the application of paste, the assessment included the severity of induced pain according to the criteria: 0=no pain, 1–3 points=slight pain, 4–6 points=moderate pain, 7–9 points=strong pain, and 10 points=very severe pain.
The NUPRO® Sensodyne® Prophylaxis Paste was applied once onto the exposed sensitive dentin for 60 s using the preventive rubber cup on a low-speed handpiece as indicated by the manufacturer.
Results
In a preliminary study, before applying the NUPRO® Sensodyne® Prophylaxis Paste, the examined teeth reacted with pain when applying both stimuli. Tactile stimulus induced the highest levels of pain (10 points) in 1.1% of cavities, in 16.3% strong pain (7–9 points), moderate pain in 42.4% (in the range of 4–6 points), small in 29.3% (1–3 points), and 10.9% of teeth did not respond with pain to tactile stimulus (Table 2). In case of dehydrating stimulus application in the initial test, no patient reported the highest level of pain. Severe pain was found (range 7–9 points) in 28.3% of studied cavities, in 38% moderate pain (4–6 points); in 21.7% slight pain l (1–3 points), and 12% felt no pain with the application of this stimulus (0 points) (Table 3).
One week after the application of the examined paste, the percentage of teeth reacting with a very strong pain decreased from 1.1% to 0, from 16.3% to 4.3% with severe pain, and 42.4% to 12% with moderate pain. In contrast, the percentage of teeth with a slight feeling of pain increased from 29.3% to 30.4%, and with no symptoms of pain from 10.9% to over 50% of studied teeth (Table 4).
A study using dehydrating stimulus 1 week after carrying out the application showed a decrease in the proportion of teeth reacting with strong pain from 28.3% to 0%, by a moderate pain from 38% to 15.2%, an increase in the percentage of people experiencing little pain from 21.7% to 37%, and the absence of pain from 12% to about 50% (Table 5). The reallocation in these groups is caused by moving the percentage of people experiencing pain from the 7–9 interval into the 1–3 interval according to the VAS scale.
Prior to the study, the subjects responded to the questions included in the questionnaire. In 73% of respondents experiencing dentin hypersensitivity, the causative agent of pain onset was cold, in 55% it was tooth brushing, and 18% of patients reported that sweet or sour foods caused a pain response. All the respondents feeling hypersensitivity characterized the pain as short-term pain and 41% as acute pain.
In 68% of respondents, all those ailments lasted longer than 1 month. Of all respondents, 59% had not used before any measures to terminate hypersensitivity. Sixty-four percent of the respondents reported tooth brushing twice a day, using a manual toothbrush in most cases (only 3 people used a power toothbrush).
In response to a question about eating habits, 45% of respondents indicated they had fresh fruit or fruit juice once a day, 32% had fresh fruit or fruit juice several times a day, 41% occasionally drank cola beverages, and 55% drank wine.
Discussion
Contemporary reports show that the treatment of dentin hypersensitivity involves interruption of the neural response to pain stimulus by topical application of preparations containing potassium salts, because potassium ions cause depolarization of nerve receptors and reduce the conductivity. A second approach is by mechanical occlusion of outlets and the lumen of open dentinal tubules, and then the formation of insoluble precipitates with the participation of compounds of calcium, fluoride, strontium, arginine, the adhesive resins or lasers [2–4,10,13,15,17–21].
Researchers interested in the problem of elimination of dentin hypersensitivity suggest, among other things, that the treatment of this problem should mimic the natural process, leading to spontaneous occlusion of open dentinal tubules [21,22]. In the natural process of tubule occlusion, saliva provides calcium and phosphorus ions, which gradually occlude the tubules by forming a superficial protective layer consisting of salivary glycoprotein aggregates, calcium, and phosphates [2,20]. This process is favored by factors that maintain a high alkaline pH
Studies on the mechanism of closure of dentinal tubules have led to the development of a new formula based on bioactive glass particles, called NovaMin. Originally, it was intended for the regeneration of bone tissue and recently was used in dentistry. The mechanism of elimination of dentin hypersensitivity by NovaMin technology is based on the formation of a mechanically and chemically resistant calcium phosphate layer, which gradually crystallizes as hydroxyapatite [25]. In contact with a moist environment (water and saliva), NovaMin releases particles of calcium and phosphorus ions protected by the glass particles so that they can be delivered to a specific location, but not into the liquid medium. The next reaction step is the exchange of sodium ions from the bioactive glass particles with hydrogen cations, which increases pH to 8–8.5 [26]. Alkaline pH promotes the release of calcium and phosphate ions, which, in the form of calcium phosphate, precipitate on the surface of the exposed dentine and in the light dentinal tubules gradually crystallize into a stable hydroxyapatite layer [23] that is resistant to repeated action of extrinsic and intrinsic acids. The formula is modeled on the natural process of closing of dentinal tubules developed by Markowitz and Pashley [22].
There are currently 2 types of prophylactic pastes with NovaMin on the market: NUPRO® Sensodyne® Polish or Stain Removal versions, and pastes without fluoride content are also available. Studies have confirmed the efficacy of calcium and sodium phospho-silicate at various concentrations both
Wang et al. [31] proved the clinical efficacy of pastes with NovaMin in an
In independent studies, Pradeep et al. and Acharya et al. demonstrated a significantly higher reduction of dentine hypersensitivity reactions in patients using a toothpaste with 5% calcium and sodium phosphosilicate at home, compared to the paste containing 5% potassium nitrate [30,32]. NovaMin also proved to be effective in eliminating dentin hypersensitivity when it was used in a concentration of 7.5% as an ingredient in a toothpaste, and compared with other formulations (potassium nitrate, fluoride, and tin) reduced the pain in a shorter time [33]. This was also confirmed in other studies [34–36].
Neuhaus et al. also achieved a statistically significant reduction in pain sensation after a single prophylactic professional application of NovaMin paste (15% calcium and sodium phosphosilicate) with and without fluoride, compared to controls. In patients with dentine hypersensitivity after scaling and polishing of the root surface, the use of NovaMin paste resulted in immediate reduction of pain sensations continuing for 28 days after the treatment administration. Immediate reduction of pain caused by a standardized touch stimulus (Yeaple Probe) was 100.5% according to the average value in the group that used fluoride toothpaste and 119.1% in the group without fluoride. The average value immediately after the prophylactic treatment of the relative reduction of pain sensation from blower air flow was 44.6% for both of the test groups and increased to about 50% after 4 weeks. The authors reported no statistically significant difference in pain reduction when comparing groups, which used professional NovaMin toothpaste with fluoride and without fluoride [29].
The results of the presented work confirm the effectiveness of the NUPRO® Sensodyne® Prophylaxis Paste after a single professional application on the exposed hypersensitive dentine. It was noticeable as an increase of percentage of tested teeth without pain and with a slight pain after tactile and dehydrating stimulus. Feeling of pain expressed as the mean value in the VAS scale was reduced in the examined group by 94%.
Conclusions
In-office use of professional prophylactic paste with NovaMin formula noticeably reduces dentin hypersensitivity 1 week after application.
References
1. Närhi M, Jyväsjärvi E, Virtannen A, Role of intradental A- and C-type fibres in dental pain mechanisms: Proc Finn Dent Soc, 1992; 88(Suppl 1); 507-16, pmid: 1508908
2. Kaczmarek U, Diagnostic and therapeutic management of dentine hypersensitivity: J Stoma, 2006; 59(7); 461-72
3. Bartold PM, Dentinal hypersensitivity: a review: Austr Dent J, 2006; 51(3); 212-18
4. Orchardson R, Gillam DG, Managing dentin hypersensitivity: J Am Dent Assoc, 2006; 137(7); 990-98, pmid: 16803826
5. Merskey H, Albe-Fessard DG, Bonica JJ, Pain terms: a list with definitions and notes on usage. Recommended by the IASP Subcommittee on taxonomy: Pain, 1979; 6(3); 249-52, pmid: 460932
6. Prudel N, Rauch J, History of anaesthesia in dentistry highlighting the work of Polish researchers – historical overview: J Stoma, 2009; 62(8); 668-77
7. Czajka-Jakubowska AE, Liu J, Chang S-R, Clarkson BH, The effect of the surface characteristics of various substrates on fluoroapatite crystal growth, alignment, and spatial orientation: Med Sci Monit, 2009; 15(6); MT84-88, pmid: 19478709
8. Dowell P, Addy M, Dentine hypersensitivity – a review. Aetiology, symptoms and theories of pain production: J Clin Periodontol, 1983; 10(4); 341-50, pmid: 6309917
9. West NX, Lussi A, Seong J, Hellwig E, Dentin hypersensitivity: pain mechanisms and aetiology of exposed cervical dentin: Clin Oral Investig, 2013; 17(Suppl 1); S9-19
10. Dababneh RH, Khouri AT, Addy M, Dentine hypersensitivity – an enigma? A review of terminology, epidemiology, mechanisms, aetiology and management: Br Dent J, 1999; 187(11); 606-11, pmid: 16163281
11. Mantzourami M, Sharma D, Dentine sensitivity: Past, present, future: J Dent, 2013; 41S4; S3-17
12. Holland GR, Narhi MN, Addy M, Gangarosa L, Orchardson R, Guidelines for the design and conduct of clinical trials on dentine hypersensitivity: J Clin Periodontol, 1997; 24(11); 808-13, pmid: 9402502
13. Cummins D, Dentin hypersensitivity: from diagnosis to a breakthrough therapy for everyday sensitivity relief: J Clin Dent, 2009; 20(1); 1-9, pmid: 19489186
14. West NX, Sanz M, Lussi A, Prevalence of dentine hypersensitivity and study of associated factors: a European population-based cross-sectional study: J Dent, 2013; 41(10); 841-51, pmid: 23911597
15. Cummins D, Recent advances in dentin hypersensitivity: clinically proven treatments for instant and lasting sensitivity relief: Am J Dent, 2010; 23(Spec No A); 3A-13A
16. Chałas R, Bachanek T, Wójcik-Chęcińska I, Zamościńska J, Using of ozone in dentin hypersensitivity. Preliminary report: Dental Forum, 2011; 39(2); 47-51
17. West N, Newcombe RG, Hughes N, A 3-day randomised clinical study investigating the efficacy of two toothpastes, designed to occlude dentine tubules, for the treatment of dentine hypersensitivity: J Dent, 2013; 41( 2); 187-94, pmid: 23160037
18. He S, Wang Y, Li X, Hu D, Effectiveness of laser therapy and topical desensitising agents in treating dentine hypersensitivity: a systematic review: J Oral Rehabil, 2011; 38(5); 348-58, pmid: 21223353
19. Addy M, Dentine hypersensitivity: new perspectives on an old problem: Int Dent J, 2002; 52(Suppl); 367-75
20. Kleinberg I, SensiStat: A new saliva-based composition for simple and effective treatment of dentinal sensitivity pain: Dent Today, 2002; 21(12); 42-47, pmid: 12572161
21. Parkinson CR, Earl JS: J Clin Dent, 2009; 20(5); 152-57, pmid: 19902639
22. Markowitz K, Pashley DH, Discovering new treatments for sensitive teeth: the long path from biology to therapy: J Oral Rehabil, 2008; 35(4); 300-15, pmid: 18321266
23. Andersson OH, Kangasniemi I: J Biomed Mater Res, 1991; 25(8); 1019-30, pmid: 1918106
24. Wefel JS, NovaMin: likely clinical success: Adv Dent Res, 2009; 21(1); 40-43, pmid: 19717409
25. Gendreau L, Barlow AP, Mason SC, Overview of the clinical evidence for the use of NovaMin in providing relief from the pain of dentin hypersensitivity: J Clin Dent, 2011; 22(3); 90-95, pmid: 21905403
26. www.nupro-sensodyne.com
27. Burwell A, Jennings D, Muscle D, Greenspan DC: J Clin Dent, 2010; 21(3); 66-71, pmid: 21207916
28. Earl JS, Leary RK, Muller KH, Physical and chemical characterization of dentin surface following treatment with NowaMin technology: J Clin Dent, 2011; 22(3); 62-67, pmid: 21905399
29. Neuhaus KW, Milleman JL, Milleman KR, Effectiveness of a calcium sodium phosphosilicate-containing prophylaxis paste in reducing dentine hypersensitivity immediately and 4 weeks after a single application: a double-blind randomized controlled trial: J Clin Periodontol, 2013; 40(4); 349-57, pmid: 23414245
30. Pradeep AR, Agarwal E, Naik SB, Bajaj P, Kalra N, Comparison of efficacy of three commercially available dentifrices [corrected] on dentinal hypersensitivity: a randomized clinical trial: Aust Dent J, 2012; 57(4); 429-34, pmid: 23186566
31. Wang Z, Jiang T, Sauro S: Aust Dent J, 2011; 56(4); 372-81, pmid: 22126346
32. Acharya AB, Surve SM, Thakur SL, A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity: J Clin Exp Dent, 2013; 5(1); 18-22
33. Sharma N, Roy S, Kakar A, Greenspan DC, Scott RA, A clinical study comparing oral formulations containing 7.5% calcium sodium phosphosilicate (NovaMin), 5% potassium nitrate, and 0.4% stannous fluoride for the management of dentin hypersensitivity: J Clin Dent, 2010; 21(3); 88-92, pmid: 21207920
34. Pradeep AR, Sharma A, Comparison of clinical efficacy of a dentifrice containing calcium sodium phosphosilicate to a dentifrice containing potassium nitrate and to a placebo on dentinal hypersensitivity: a randomized clinical trial: J Periodontol, 2010; 81(8); 1167-73, pmid: 20370417
35. Litkowski L, Greenspan DC, A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity – proof of principle: J Clin Dent, 2010; 21(3); 77-81, pmid: 21207918
36. Shivaprasad BM, Padmavati P, Sanghani NN, Chair side application of NovaMin for treatment of dentinal hypersensitivity – a novel technique: J Clin Diagn Res, 2014; 8(10); 2C05-2C08
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






